Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Zoom
ZM
|
+$96M |
| 2 |
Match Group
MTCH
|
+$81.3M |
| 3 |
Peloton Interactive
PTON
|
+$75.6M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$55.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$50.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$201M |
| 2 |
Microsoft
MSFT
|
+$112M |
| 3 |
IAC Inc
IAC
|
+$77.1M |
| 4 |
Amazon
AMZN
|
+$73.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$52.8M |
Sector Composition
| 1 | Technology | 26.26% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Communication Services | 10.36% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1176
LivaNova
LIVN
$3.07B
| $4.98M | ﹤0.01% |
110,119
+2,100
| +2% | +$94.9K |
|
1177
FNB Corp
FNB
$5.89B
| $4.96M | ﹤0.01% |
732,215
+6,700
| +0.9% | +$45.4K |
|
1178
Bombardier Recreational Products
DOOO
$4.7B
| $4.96M | ﹤0.01% |
94,300
-2,000
| -2% | -$105K |
|
1179
Tenet Healthcare
THC
$17B
| $4.94M | ﹤0.01% |
201,700
+3,800
| +2% | +$93.1K |
|
1180
Twist Bioscience
TWST
$1.53B
| $4.94M | ﹤0.01% |
65,000
+2,300
| +4% | +$175K |
|
1181
Agios Pharmaceuticals
AGIO
$2.14B
| $4.92M | ﹤0.01% |
140,560
+2,900
| +2% | +$102K |
|
1182
Merit Medical Systems
MMSI
$5.07B
| $4.92M | ﹤0.01% |
113,000
+2,100
| +2% | +$91.4K |
|
1183
Alcoa
AA
$8.61B
| $4.9M | ﹤0.01% |
421,394
+6,400
| +2% | +$74.4K |
|
1184
Lightspeed Commerce
LSPD
$1.61B
| $4.87M | ﹤0.01% |
+152,700
| New | +$4.87M |
|
|
TRTN
1185
DELISTED
Triton International Limited
TRTN
| $4.86M | ﹤0.01% |
119,500
-1,200
| -1% | -$48.8K |
|
1186
CVB Financial
CVBF
$2.77B
| $4.85M | ﹤0.01% |
291,800
-5,300
| -2% | -$88.1K |
|
1187
AppFolio
APPF
$9.9B
| $4.84M | ﹤0.01% |
34,100
+1,100
| +3% | +$156K |
|
1188
Applied Industrial Technologies
AIT
$9.94B
| $4.83M | ﹤0.01% |
87,700
+1,400
| +2% | +$77.1K |
|
1189
EPR Properties
EPR
$4.45B
| $4.82M | ﹤0.01% |
175,388
| – | – |
|
1190
Arcosa
ACA
$4.67B
| $4.82M | ﹤0.01% |
109,300
+1,500
| +1% | +$66.1K |
|
1191
Allogene Therapeutics
ALLO
$251M
| $4.82M | ﹤0.01% |
127,800
+2,400
| +2% | +$90.5K |
|
|
STAY
1192
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $4.81M | ﹤0.01% |
402,286
+6,600
| +2% | +$78.9K |
|
1193
Evertec
EVTC
$2.14B
| $4.81M | ﹤0.01% |
138,474
+1,900
| +1% | +$65.9K |
|
1194
Ovintiv
OVV
$10.8B
| $4.81M | ﹤0.01% |
588,907
+8,960
| +2% | +$73.1K |
|
1195
iRobot
IRBT
$107M
| $4.8M | ﹤0.01% |
63,300
| – | – |
|
1196
Hillenbrand
HI
$1.73B
| $4.8M | ﹤0.01% |
169,359
+2,600
| +2% | +$73.7K |
|
|
HMSY
1197
DELISTED
HMS Holdings Corp.
HMSY
| $4.8M | ﹤0.01% |
200,400
+3,800
| +2% | +$91K |
|
1198
California Water Service
CWT
$2.76B
| $4.8M | ﹤0.01% |
110,400
+3,000
| +3% | +$130K |
|
1199
Under Armour
UAA
$2.08B
| $4.8M | ﹤0.01% |
427,100
+2,674
| +0.6% | +$30K |
|
1200
CNX Resources
CNX
$4.25B
| $4.79M | ﹤0.01% |
507,758
+91,100
| +22% | +$860K |
|